Zymeworks (ZYME) Current Deferred Revenue: 2021-2023

Historic Current Deferred Revenue for Zymeworks (ZYME) over the last 1 years, with Sep 2023 value amounting to $93,000.

  • Zymeworks' Current Deferred Revenue fell 99.72% to $93,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $93,000, marking a year-over-year decrease of 99.72%. This contributed to the annual value of $32.9 million for FY2022, which is negligibly% changed negligibly from last year.
  • Per Zymeworks' latest filing, its Current Deferred Revenue stood at $93,000 for Q3 2023, which was down 99.48% from $17.8 million recorded in Q2 2023.
  • In the past 5 years, Zymeworks' Current Deferred Revenue ranged from a high of $32.9 million in Q4 2021 and a low of $93,000 during Q3 2023.
  • Moreover, its 3-year median value for Current Deferred Revenue was $25.4 million (2021), whereas its average is $19.8 million.
  • Data for Zymeworks' Current Deferred Revenue shows a maximum YoY plummeted of 99.72% (in 2023) over the last 5 years.
  • Over the past 3 years, Zymeworks' Current Deferred Revenue (Quarterly) stood at $32.9 million in 2021, then remained steady at $32.9 million in 2022, then plummeted by 99.72% to $93,000 in 2023.
  • Its Current Deferred Revenue stands at $93,000 for Q3 2023, versus $17.8 million for Q2 2023 and $2.4 million for Q1 2023.